CRM closed at $188.38 on July 29, 2026, up 4.6% from the prior day and extending the bounce from the June $146 low. The at 20.66 is in risk-off territory, and the 10Y yield at 4.62% continues to pressure growth multiples, but CRM's low valuation (forward 12.1x, FCF yield 10.73%, 0.75) provides a significant cushion. Technically, the stock has reclaimed the 50-day ($171.11) and ($168.85), and the histogram has expanded to +2.23 on above-average volume, indicating improving short-term momentum. at 64.74 is bullish but not overbought, while remains negative (-220M) but trending higher, suggesting distribution is abating. Price is still well below the 200-day ($202.07), keeping the long-term trend bearish but the gap is narrowing. Fundamentals remain compelling: revenue growth of 13.3%, earnings growth of 52.2%, and a 100% beat rate over the last 5 quarters. Estimate revisions are extremely positive with 44 upgrades for the current year in the last 7 days and zero downgrades, and the trend has risen from $13.20 to $14.13 over 60 days. The mean analyst target is $241.72, implying 28% upside, though the wide range ($160-$475) reflects high uncertainty. The $1.6B VA contract win announced July 24 provides tangible validation of the AI agent thesis and opens a government vertical. Insider activity shows only routine CEO 10b5-1 sales, no red flags. The key risk is the technical overhang from the death cross and macro headwinds from rising rates and elevated , but the deep valuation and strong AI monetization support a long-term BUY. The next earnings report is 34 days away, a moderate event-risk window.
Decision
Live price
$178.97
Recommendation score
75%
75%
Confidence
75%
75%
Outlook by horizon
1M
BUY
Near
6M
BUY
Mid
1Y
BUY
Long
Primary catalyst
The $1.6 billion VA contract win on July 24 is the most impactful, providing tangible evidence of AI agent adoption in government, partially offsetting negative sentiment from the Morgan Stanley downgrade.
Given the at 20.66 (risk-off) and elevated single-stock volatility ( 4.3%), use standard positioning but avoid overweighting. Long-term investors can scale in on pullbacks toward $170-$175. The bounce above is encouraging but not yet confirmed; wait for a break above $190 or a retest of $170 support before adding. Reduce if spikes above 25 or stock closes below $165.
Thesis Snapshot
Why It Works
CRM is an undervalued cash machine with 10.73% FCF yield, 52% growth, and a hidden $5B Anthropic stake. The 30% drawdown from the 52-week high is overdone and offers a generational entry. The strong estimate revision trend suggests fundamentals are improving despite near-term noise. AI agent monetization via Agentforce provides a powerful growth catalyst, now validated by a $1.6B government contract. The negative sentiment from downgrades may create a buying opportunity for long-term investors.
What Breaks It
Morgan Stanley's downgrade highlights legitimate concerns: AI monetization may take longer than expected, legacy businesses continue to drag, and enterprise IT spending could slow if the macro environment deteriorates. The technical breakdown below the 200-day and still-negative (though improving) suggest lack of full institutional support. Net debt of $30.7B is a concern if growth decelerates. Elevated yields could keep multiples compressed, and the stock could retest the 52-week low if macro conditions worsen.
A weekly close below $146.32 (52-week low) on above-average volume would invalidate the value thesis and suggest further downside to $130-140.
Macro deterioration: spikes above 25 or 10Y yield rises above 5%, compressing multiples further and triggering a broad risk-off move.
Enterprise IT spending slowdown: if broader sector spending weakens, estimate revisions could reverse despite current positive trend.
Agentforce adoption disappointment: if next earnings show slower-than-expected AI agent uptake, the thesis could unravel.
Anthropic IPO delay or disappointing valuation reduces hidden asset value and could trigger selling.
Watch Next
Next earnings: Sep 2, 2026
The $1.6 billion VA contract win on July 24 is the most impactful, providing tangible evidence of AI agent adoption in government, partially offsetting negative sentiment from the Morgan Stanley downgrade.
Signal Dashboard
Decision inputs
6 signals
Fundamental
28.3%
Upside to analyst mean target
of 12.1x and of 0.75 are deeply attractive relative to 52% growth and 10.73% FCF yield. of 13.9x is below the software sector median. The stock is priced for a recession that guidance does not support. The wide analyst target spread ($160-$475) implies high uncertainty, but the mean target of $241.72 suggests 28% upside. The VA contract win strengthens the growth thesis. Valuation strongly supports a long-term BUY.
Technical
Bullish
Trend quality
Price at $188.38 is above ($168.85) and ($171.11), indicating a short-term uptrend, but remains below ($202.07), maintaining a bearish long-term trend (death cross still in effect). The recent bounce from $146.32 (June 22 low) has been strong, lifting price above key moving averages and suggesting a potential trend change if confirmed by sustained volume.
Earnings
34d
Accelerating
Q1 FY2027 (Apr 2026) delivered a 24.1% beat ($3.88 vs $3.13), with Agentforce ARR surpassing $1.2B, validating the AI monetization thesis.
News
Mixed-Bullish
Headline tone
The $1.6 billion VA contract win on July 24 is the most impactful, providing tangible evidence of AI agent adoption in government, partially offsetting negative sentiment from the Morgan Stanley downgrade.
Macro
Risk-Off
4.62% 10Y / 20.7 VIX
With at 20.66 (elevated) and 10Y yield at 4.62% (rising), the regime is risk-off. This environment typically penalizes high-beta growth names, but CRM's low forward and high FCF yield provide a valuation cushion that partially offsets macro headwinds. However, realized volatility (48.5% 20-day) means the stock remains highly sensitive to risk-off shifts.
Stability
Balanced Growth
Core Growth
Salesforce combines strong business quality (77.6% gross margin, 30.1% margin) with deep value (forward 12.1x, FCF yield 10.73%, 0.75). However, net debt of $30.7B ( 124%) and elevated realized volatility (48.5% 20-day) result in high drawdown risk. The asset is appropriate as a core growth holding for long-term investors who can tolerate near-term volatility and have a multi-year horizon.
Analyst Spread
Mean Target
$241.72
High / Low
$160 / $475
Median Target
$236.00
Consensus range
$160 - $475
— analysts
Mean
$160$242$475
Consensus
With a mean target of $241.72 (28% upside) and a wide spread ($160-$475), analysts see substantial value but disagree on timing. Recent actions are mixed: Morgan Stanley downgrade to Equal-Weight ($185), CLSA initiate Hold ($165), Keybanc downgrade to Sector Weight, while Guggenheim upgraded to Buy ($228). The consensus breakdown shows 5 strong buys, 34 buys, 12 holds, and 2 strong sells. The bias remains cautiously bullish with increased dispersion.
Positioning Pulse
Insider Signal
Neutral
Net Bias
Sell-heavy
Insider Own.
3.0%
Institutional Own.
94.1%
Interpretation
Insider selling is programmatic and not indicative of fundamental concern; Benioff's sales are pre-scheduled and small relative to his holdings. No red flags.
Notable activity
CEO Marc Benioff continues routine 10b5-1 sales of ~2,250 shares per transaction, totaling ~$0.5M each over recent months. Director David Blair Kirk sold 215 shares in a trust transaction. No open-market purchases were observed.
Market Context
Industry
Software - Application
Mixed-Bullish
Sentiment
26
Tracked names
14
Grouping
industry
Software - Application industry is currently Mixed-Bullish with an average recommendation score near 60. capital and conviction are improving across the group, and leadership is concentrated in SAP, UBER, NOW.
Rotation Drivers
Average recommendation deltas are trending higher across Software - Application industry, which suggests improving risk appetite inside the group.
10 names are rated bullish versus 2 bearish names, keeping the group tone mixed-bullish.
Leadership is concentrated in SAP, UBER, NOW, so those names are the cleanest read on group-level capital rotation.
Autonomous AI agents for customer service are a transformative theme in enterprise software. Salesforce's Agentforce is a leader with >$1.2B ARR and accelerating adoption, now validated by a $1.6B government contract. However, Morgan Stanley's downgrade raises concerns about the pace of AI monetization and legacy drag, suggesting the market may be overestimating near-term adoption. The long-term opportunity remains intact, and the VA deal provides a strong catalyst.
The VA contract win demonstrates real-world deployment of AI agents at scale, reinforcing the investment case for Agentforce. The rotation from semiconductors to software stocks paused after the Morgan Stanley downgrade, but the fundamental case for AI agents as a productivity driver remains strong.
Enterprise cost-cutting drives demand for AI agents that automate workflows, providing ROI even in tight budgets.
Government adoption of AI agents, as evidenced by the VA contract, opens a new vertical.
Key Stats
23 metrics total
Market Cap
$154.28B
P/E (TTM)
21.9
Forward P/E
12.1
Revenue Growth
13.3%
ROE
16.9%
Beta
1.18
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
3.6
Price / Book
4.5
EV / EBITDA
13.9
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
77.6%
Operating Margin
21.8%
Debt / Equity
124.3
Current Ratio
0.79x
Quick Ratio
0.62x
Positioning & Range
Short interest and 52-week location.
Short % Float
6.6%
Short Ratio
2.85x
52W High
$269.11
52W Low
$146.32
From 52W High
-30.0%
From 52W Low
28.8%
Company Classification
Sector and industry context.
Sector
Technology
Industry
Software - Application
Additional Signals
Free Cash Flow
$16552999936.00
Detailed Analysis
Valuation
of 12.1x and of 0.75 are deeply attractive relative to 52% growth and 10.73% FCF yield. of 13.9x is below the software sector median. The stock is priced for a recession that guidance does not support. The wide analyst target spread ($160-$475) implies high uncertainty, but the mean target of $241.72 suggests 28% upside. The VA contract win strengthens the growth thesis. Valuation strongly supports a long-term BUY.
Balance Sheet
Net debt of $30.7B ( 124%) is elevated but manageable given operating cash flow of $15.2B. The cash-to-debt ratio of 0.28 and current ratio of 0.79 indicate short-term liquidity pressure, but operating cash flow to debt of 0.36x provides adequate coverage. The balance sheet is not fortress-like but cash flows support the debt. of 16.9% is solid.
Growth
Revenue growth of 13.3% YoY is steady, while earnings growth of 52.2% reflects margin expansion from cost controls and AI product mix. Agentforce autonomous agents are a high-growth catalyst at >$1.2B ARR and accelerating, and the VA contract win opens a government vertical. The growth trajectory remains intact; near-term macro headwinds could weigh, but the fundamental trend is positive.
Business Quality
Gross margins of 77.6% and operating margins of 21.8% demonstrate pricing power and scale. of 16.9% is solid, and of 5.7% is reasonable. The Data Cloud creates a durable moat, and enterprise switching costs are high. Business quality supports a premium multiple, not a single-digit .
Capital Allocation
Management aggressively buys back shares, which is accretive at current prices, and pays a 1.0% dividend. The $5B venture stake in Anthropic adds optionality. Capital allocation is disciplined and shareholder-friendly.
Estimate Revisions
estimates for the current year have been revised up 44 times in the last 7 days with zero downgrades, moving from $13.20 to $14.13 over 60 days. Current quarter estimates are stable at $3.27. The trend remains strongly positive, confirming that fundamental momentum is improving despite market concerns over sector spending. The VA contract win may lead to further upward revisions.